PDRN has published clinical data in lichen sclerosus and addresses exactly what steroids cannot: tissue depletion, poor vascularization, and slow healing that persist even when inflammation is controlled. Here is what the research actually shows.
Most LS flares are treated with anti inflammatory medication. What is almost never addressed is the barrier, the mechanism through which ordinary daily life keeps restarting the disease. This article explains why, and what repair actually requires.
